Beyond Air (XAIR) Cash from Operations (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172.53% |
| Sep 30, 2025 | 93.93% |
| Jun 30, 2025 | 35.15% |
| Mar 31, 2025 | -320.04% |
| Dec 31, 2024 | 30.21% |
| Sep 30, 2024 | 76.75% |
| Jun 30, 2024 | 5.08% |
| Mar 31, 2024 | 22.38% |
| Dec 31, 2023 | 3.51% |
| Sep 30, 2023 | 16.52% |
| Jun 30, 2023 | -103.23% |
| Mar 31, 2023 | 0.81% |
| Dec 31, 2022 | -19.46% |
| Sep 30, 2022 | -4.14% |
| Jun 30, 2022 | 13.42% |
| Mar 31, 2022 | -225.40% |
| Dec 31, 2021 | 26.00% |
| Sep 30, 2021 | 227.62% |
| Jun 30, 2021 | 29.65% |
| Mar 31, 2021 | -5.79% |
| Dec 31, 2020 | -58.53% |
| Sep 30, 2020 | 39.47% |
| Jun 30, 2020 | -12.88% |
| Mar 31, 2020 | -2.15% |
| Dec 31, 2019 | -74.68% |
| Sep 30, 2019 | 6.41% |
| Jun 30, 2019 | -141.05% |
| Mar 31, 2019 | 531.94% |
| Dec 31, 2018 | 8.97% |
| Sep 30, 2018 | 21.75% |
| Jun 30, 2018 | -31.70% |
| Mar 31, 2018 | 64.34% |
| Dec 31, 2017 | -250.47% |
| Sep 30, 2017 | 17.70% |
| Jun 30, 2017 | 23.11% |
| Mar 31, 2017 | -698.70% |
| Dec 31, 2016 | -147.32% |
| Sep 30, 2016 | 0.88% |
| Jun 30, 2016 | 40.53% |